| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.22B | 17.34B | 16.25B | 15.42B | 13.50B | 11.49B |
| Gross Profit | 4.64B | 4.98B | 4.63B | 4.25B | 3.54B | 2.78B |
| EBITDA | 1.90B | 2.05B | 2.06B | 1.94B | 1.43B | 942.31M |
| Net Income | 1.08B | 1.15B | 1.21B | 1.09B | 1.25B | 461.13M |
Balance Sheet | ||||||
| Total Assets | 14.53B | 16.51B | 14.56B | 13.57B | 10.18B | 8.89B |
| Cash, Cash Equivalents and Short-Term Investments | 2.64B | 3.03B | 3.50B | 2.95B | 1.79B | 1.27B |
| Total Debt | 3.27B | 3.19B | 3.44B | 3.37B | 2.26B | 2.84B |
| Total Liabilities | 5.91B | 6.19B | 6.01B | 5.96B | 4.58B | 4.75B |
| Stockholders Equity | 8.61B | 10.32B | 8.55B | 7.61B | 5.61B | 4.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 136.09M | 909.52M | 1.06B | 1.10B | 276.62M |
| Operating Cash Flow | 0.00 | 1.47B | 1.51B | 1.59B | 1.35B | 571.12M |
| Investing Cash Flow | 0.00 | -1.49B | -829.31M | -564.36M | -244.50M | -229.32M |
| Financing Cash Flow | 0.00 | -557.24M | -80.12M | -42.79M | -665.97M | -189.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥10.51B | 8.40 | ― | 3.11% | 6.73% | -4.69% | |
65 Neutral | ¥13.64B | 9.53 | ― | 1.43% | 5.88% | 180.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | ¥5.43B | 117.77 | ― | 0.84% | ― | ― | |
48 Neutral | ¥14.10B | 51.12 | ― | 1.61% | 2.00% | -44.01% | |
46 Neutral | ¥13.66B | -20.95 | ― | 1.90% | 3.69% | -63.11% | |
42 Neutral | ¥12.01B | -363.47 | ― | 1.38% | 9.08% | -156.99% |